Atlantic Coastal Acquisition Corp II
A blank-check company, or SPAC, formed in Delaware in 2021 to raise money through an initial public offering with the goal of buying and taking public a private business. It originally set its sights on the mobility sector, but in 2024 it instead merged with Abpro Corporation, a biotech firm developing antibody therapies for cancer and other diseases, and the combined company now runs as Abpro Holdings. A fun twist: a company that started hunting for a ride-sharing or auto startup ended up bringing a drug developer to the stock market instead.
Warrant to purchase one share of Series A Common Stock at 1.50 per share — Merged with Abpro Holdings Inc in November 2024; warrants changed to ABPWW
No filing summaries or text available for this security.